Bile Acids in Serum and broncho-alveolar lavage fluid

Bile Acids in Serum and broncho-alveolar lavage fluid - BASeBAL

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016645

Enrollment

Registered

2019-01-30

Start date

2019-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J80

Interventions

Group 1: Patients with ARDS At four time points (day of diagnosis and three other clinically indicated times), bronchoalveolar lavage is performed and material is collected. At the same time a serum s

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: • Women and men • Age> 18 years <90 years • Patients in the operative intensive care unit of the Department of Anaesthesiology (0119) • Diagnosis of ARDS (control group without impaired lung function) • There is an oral and / or written explanation Presence of written consent (patient / legal representative)

Exclusion criteria

Exclusion criteria: • No consent Rejection study participation

Design outcomes

Primary

Measure	Time frame
Demonstration of a barrier disorder of the lung for bile acids Detection of a linear relationship bile acids serum - bronchalveolar lavagefluid (BAL fluid)	—

Secondary

Measure	Time frame
Evidence of a correlation bile acids BAL fluid - ARDS severity	—

Countries

Germany

Contacts

Public ContactLars-Olav Harnisch

Universitätsmedizin Göttingen

lars-olav.harnisch@med.uni-goettingen.de05513963579

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026